共 10 条
[1]
Semaphorin 3A suppresses VEGF-mediated angiogenesis yet acts as a vascular permeability factor. Acevedo Lisette M,Barillas Samuel,Weis Sara M,G?thert Joachim R,Cheresh David A. Blood . 2008
[2]
Toward Wisdom From Failure: Lessons From Neuroprotective Stroke Trials and New Therapeutic Directions[J] . David J. Gladstone,Sandra E. Black,Antoine M. Hakim.  Stroke: Journal of the American Heart Association . 2002 (8)
[4]
Withania somnifera : An Indian ginseng[J] . S.K. Kulkarni,Ashish Dhir.  Progress in Neuropsychopharmacology & Biological Psychiatry . 2007 (5)
[5]
Heart disease and stroke statistics--2014 update:a report from the American Heart Association. Go AS,Mozaffarian D,Roger VL,Benjamin EJ,Berry JD,Blaha MJ,Dai S,Ford ES,Fox CS,Franco S,Fullerton HJ,Gillespie C,Hailpern SM,Heit JA,Howard VJ,Huffman MD,Judd SE,Kissela BM,Kittner SJ,Lackland DT,Lichtman JH,Lisabeth LD,Mackey RH,Magid DJ,Marcus GM,Marel. Circulation . 2014
[6]
Withania somnifera improves ischemic stroke outcomes by attenuating PARP1-AIF-mediatedcaspase-independent apoptosis. Raghavan A,Shah ZA. Molecular Neurobiology . 2014
[7]
Acute stroke therapy with tissue plasminogen activator (tPA) since it was approved by the U.S. Food and Drug Administration (FDA). Zivin Justin A. Annals of Neurology . 2009
[8]
Wnt signaling enhances neurogenesis and improves neurological function after focal ischemic injury. Shruster Adi,Ben-Zur Tali,Melamed Eldad,Offen Daniel. PloS one . 2012
[9]
Role and therapeutic potential of VEGF in the nervous system. Ruiz de Almodovar Carmen,Lambrechts Diether,Mazzone Massimiliano,Carmeliet Peter. Physiological Reviews . 2009
[10]
Angiogenesis, Neurogenesis and Neuroplasticity in Ischemic Stroke. M. Angels Font,Adria Arboix,Jerzy Krupinski. Current Cardiology Reviews . 2010